The Recall Desk
SevereFDA (Food)·F-2399-2014·Announced 2014-09-03

Beta Labs Recalls Phentylene Dietary Supplement Containing DMAA

Beta Labs is recalling Phentylene capsules because they contain DMAA, a substance not permitted in dietary supplements.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The agency classification is FDA Class I, which mandates a severity score of at least 4 according to the rubric.

Plain-English summary

Beta Labs, LTD is recalling Phentylene (TM), Pharmaceutical Grade, With 50 mg of Ephedra Extract, 90 capsules. The product is distributed by Beta Labs, LTD in Newark, DE, and carries UPC 670541599822. The recall involves 2,154 units of Lot # 58800512, which has an expiration date of 05/16.

The recall is being conducted because the products contain DMAA, also known as 1,3-dimethylamylamine, methylhexamine, or geranium extract. DMAA is not permitted in dietary supplements. The product was distributed nationwide and in the UK.

Consumers who have purchased this product should stop using it and contact the recalling firm for further instructions.

The recalled product

Product
PHENTALENE (TM), PHARMACEUTICAL GRADE, With 50 mg of Ephedra Extract, 90 CAPSULES, Distributed by Beta Labs, LTD, Newark, DE 19711, UPC 670541599822
Manufacturer
Beta Labs
Affected units
2,154

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot # 58800512
  • Exp 05/16

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 4 recalled by Beta Labs under a single FDA (Food) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 4 products in this recall →